SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001399529-20-000045
Filing Date
2020-06-17
Accepted
2020-06-16 17:33:02
Documents
15
Period of Report
2020-06-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K drna-20200615.htm   iXBRL 8-K 91941
2 EX-99.1 exhibit991non-employee.htm EX-99.1 18258
  Complete submission text file 0001399529-20-000045.txt   260957

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT drna-20200615.xsd EX-101.SCH 2433
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT drna-20200615_cal.xml EX-101.CAL 720
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT drna-20200615_def.xml EX-101.DEF 1657
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT drna-20200615_lab.xml EX-101.LAB 23970
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT drna-20200615_pre.xml EX-101.PRE 12656
12 EXTRACTED XBRL INSTANCE DOCUMENT drna-20200615_htm.xml XML 10940
Mailing Address 33 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 33 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36281 | Film No.: 20967419
SIC: 2834 Pharmaceutical Preparations